Bill Text: TX HB2882 | 2017-2018 | 85th Legislature | Introduced
Bill Title: Relating to modification of certain prescription drug benefits and coverage offered by certain health benefit plans.
Sponsorship: Partisan Bill (Republican 2)
Status: (Introduced - Dead) 2017-05-02 - Left pending in committee [HB2882 Detail]
Download: Texas-2017-HB2882-Introduced.html
| 85R2884 SMT-F | ||
| By: Oliverson | H.B. No. 2882 | |
|
|
||
|
|
||
| relating to modification of certain prescription drug benefits and | ||
| coverage offered by certain health benefit plans. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Section 1369.0541, Insurance Code, is amended by | ||
| amending Subsections (a) and (b) and adding Subsection (b-1) to | ||
| read as follows: | ||
| (a) Except as provided by Section 1369.055(a-1) and | ||
| Subsection (b-1) of this section, a [ |
||
| may modify drug coverage provided under a health benefit plan if: | ||
| (1) the modification occurs at the time of coverage | ||
| renewal; | ||
| (2) the modification is effective uniformly among all | ||
| group health benefit plan sponsors covered by identical or | ||
| substantially identical health benefit plans or all individuals | ||
| covered by identical or substantially identical individual health | ||
| benefit plans, as applicable; and | ||
| (3) not later than the 60th day before the date the | ||
| modification is effective, the issuer provides written notice of | ||
| the modification to the commissioner, each affected group health | ||
| benefit plan sponsor, each affected enrollee in an affected group | ||
| health benefit plan, and each affected individual health benefit | ||
| plan holder. | ||
| (b) Modifications affecting drug coverage that require | ||
| notice under Subsection (a) include: | ||
| (1) removing a drug from a formulary; | ||
| (2) adding a requirement that an enrollee receive | ||
| prior authorization for a drug; | ||
| (3) imposing or altering a quantity limit for a drug; | ||
| (4) imposing a step-therapy restriction for a drug; | ||
| [ |
||
| (5) moving a drug to a higher cost-sharing tier; | ||
| (6) increasing a coinsurance, copayment, deductible, | ||
| or other out-of-pocket expense that an enrollee must pay for a drug; | ||
| and | ||
| (7) reducing the maximum drug coverage amount [ |
||
|
|
||
| (b-1) Modifications affecting drug coverage that are more | ||
| favorable to enrollees may be made at any time and do not require | ||
| notice under Subsection (a), including: | ||
| (1) the addition of a drug to a formulary; | ||
| (2) the reduction of a coinsurance, copayment, | ||
| deductible, or other out-of-pocket expense that an enrollee must | ||
| pay for a drug; and | ||
| (3) the removal of a utilization review requirement. | ||
| SECTION 2. Section 1369.055, Insurance Code, is amended by | ||
| adding Subsections (a-1) and (a-2) to read as follows: | ||
| (a-1) On renewal of a health benefit plan, the plan issuer | ||
| may not modify an enrollee's contracted benefit level for any | ||
| prescription drug that was approved or covered under the plan in the | ||
| immediately preceding plan year and prescribed during that year for | ||
| a medical condition or mental illness of the enrollee if: | ||
| (1) the enrollee was covered by the health benefit | ||
| plan on the date immediately preceding the renewal date; | ||
| (2) a physician or other prescribing provider | ||
| appropriately prescribes the drug for the medical condition or | ||
| mental illness; | ||
| (3) the prescribing provider in consultation with the | ||
| enrollee determines that the drug is the most appropriate course of | ||
| treatment; and | ||
| (4) the drug is considered safe and effective for | ||
| treating the enrollee's medical condition or mental illness. | ||
| (a-2) Modifications prohibited under Subsection (a-1) | ||
| include: | ||
| (1) removing a drug from a formulary; | ||
| (2) adding a requirement that an enrollee receive | ||
| prior authorization for a drug; | ||
| (3) imposing or altering a quantity limit for a drug; | ||
| (4) imposing a step-therapy restriction for a drug; | ||
| and | ||
| (5) moving a drug to a higher cost-sharing tier. | ||
| SECTION 3. The changes in law made by this Act apply only to | ||
| a health benefit plan that is delivered, issued for delivery, or | ||
| renewed on or after January 1, 2018. A health benefit plan | ||
| delivered, issued for delivery, or renewed before January 1, 2018, | ||
| is governed by the law as it existed immediately before the | ||
| effective date of this Act, and that law is continued in effect for | ||
| that purpose. | ||
| SECTION 4. This Act takes effect September 1, 2017. | ||
